BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Novocure Reports Third Quarter 2021 Financial Results and Provides Company Update

  Novocure reported financial results for the quarter ended September 30, 2021, highlighting commercial strength and strategic investment across clinical, product development and commercial initiatives intended to fuel future growth.

  October 28, 2021

   · 

  15 min read
• Business

  Teleflex Announces Quarterly Dividend - Oct 28, 2021

  Teleflex Incorporated announced that its Board of Directors declared a quarterly cash dividend of thirty-four cents per share of common stock.

  October 28, 2021

   · 

  1 min read
• Policy

  Pfizer and BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs

  Pfizer Inc. and BioNTech SE announced that the U.S. government has purchased 50 million more doses of the companies’ COVID-19 vaccine.

  October 28, 2021

   · 

  20 min read
• Novadip Biosciences announces EUR 19 million Series B financing backed by international investors

  Novadip Biosciences today announced that it has raised €19 million in the first close of a Series B financing

  October 28, 2021

   · 

  7 min read
• Business

  Fulcrum Therapeutics™ to Host Third Quarter 2021 Financial Results Conference Call and Webcast on Thursday, November 4, 2021 at 8:00 a.m. ET

  Fulcrum Therapeutics, Inc. today announced that its third quarter 2021 financial results will be released on Thursday, November 4, 2021 before the U.S. financial markets open.

  October 28, 2021

   · 

  1 min read
• Drug Development

  Optinose Completes Patient Recruitment in Second Pivotal Trial for XHANCE in Chronic Sinusitis

  Optinose today announced it has successfully completed recruitment in the second of two Phase 3b pivotal clinical trials to evaluate the safety and efficacy of XHANCE® (fluticasone propionate) nasal spray as a treatment for patients with chronic sinusitis (CS).

  October 28, 2021

   · 

  6 min read
• Business

  Baudax Bio to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4, 2021

  Baudax Bio, Inc. today announced that it will report third quarter 2021 financial results on Thursday, November 4, 2021.

  October 28, 2021

   · 

  3 min read
• Business

  Chimerix to Report Third Quarter 2021 Financial Results and Provide an Operational Update on November 4, 2021

  Chimerix today announced that it will host a live conference call and audio webcast on Thursday, November 4, 2021 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2021, and to provide an operational update.

  October 28, 2021

   · 

  2 min read
• Biotech Beach

  NuVasive to Sponsor and Participate in Society for Minimally Invasive Spine Surgery Annual Forum ’21

  NuVasive, Inc. today announced it will sponsor and participate in the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum ’21 in Las Vegas from October 28 to 30, 2021.

  October 28, 2021

   · 

  4 min read
• Business

  Blueprint Medicines Reports Third Quarter 2021 Financial Results

  Blueprint Medicines Corporation today reported financial results and provided a business update for the third quarter ended September 30, 2021.

  October 28, 2021

   · 

  12 min read